Source Name	Characteristics[organism]	Characteristics[organism part]	Characteristics[age]	Characteristics[developmental stage]	Characteristics[sex]	characteristics[ancestry category]	characteristics[cell type]	Characteristics[disease]	Characteristics[phenotype]	assay name	comment[label]	comment[fraction identifier]	comment[MS2 mass analyzer]	comment[instrument]	comment[file uri]	comment[dissociation method]	comment[cleavage agent details]	comment[modification parameters]	comment[modification parameters]	comment[modification parameters]	comment[precursor mass tolerance]	comment[fragment mass tolerance]	comment[data file]	Material Type
Sample 1	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	not available	run 1	NT=SILAC;AC=MS:1002611	2	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110610_Q2_TaGe_SA_SSM1_2.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110610_Q2_TaGe_SA_SSM1_2.raw	cell
Sample 1	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	not available	run 2	NT=SILAC;AC=MS:1002611	3	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110610_Q2_TaGe_SA_SSM1_3.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110610_Q2_TaGe_SA_SSM1_3.raw	cell
Sample 1	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	not available	run 3	NT=SILAC;AC=MS:1002611	4	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110610_Q2_TaGe_SA_SSM1_4.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110610_Q2_TaGe_SA_SSM1_4.raw	cell
Sample 1	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	not available	run 4	NT=SILAC;AC=MS:1002611	5	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110610_Q2_TaGe_SA_SSM1_5.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110610_Q2_TaGe_SA_SSM1_5.raw	cell
Sample 1	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	not available	run 5	NT=SILAC;AC=MS:1002611	6	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110610_Q2_TaGe_SA_SSM1_6.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110610_Q2_TaGe_SA_SSM1_6.raw	cell
Sample 2	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	not available	run 6	NT=SILAC;AC=MS:1002611	1	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110610_Q2_TaGe_SA_SSM2_1.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110610_Q2_TaGe_SA_SSM2_1.raw	cell
Sample 2	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	not available	run 7	NT=SILAC;AC=MS:1002611	2	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110610_Q2_TaGe_SA_SSM2_2_110612101420.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110610_Q2_TaGe_SA_SSM2_2_110612101420.raw	cell
Sample 2	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	not available	run 8	NT=SILAC;AC=MS:1002611	3	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110610_Q2_TaGe_SA_SSM2_3_110612155437.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110610_Q2_TaGe_SA_SSM2_3_110612155437.raw	cell
Sample 2	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	not available	run 9	NT=SILAC;AC=MS:1002611	4	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110610_Q2_TaGe_SA_SSM2_4_110612200610.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110610_Q2_TaGe_SA_SSM2_4_110612200610.raw	cell
Sample 2	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	not available	run 10	NT=SILAC;AC=MS:1002611	5	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110610_Q2_TaGe_SA_SSM2_5.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110610_Q2_TaGe_SA_SSM2_5.raw	cell
Sample 2	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	not available	run 11	NT=SILAC;AC=MS:1002611	6	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110610_Q2_TaGe_SA_SSM2_6.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110610_Q2_TaGe_SA_SSM2_6.raw	cell
Sample 3	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	ERPR	run 12	NT=SILAC;AC=MS:1002611	1	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110612_EXQ1_TaGe_SA_BC5_1.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110612_EXQ1_TaGe_SA_BC5_1.raw	cell
Sample 3	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	ERPR	run 13	NT=SILAC;AC=MS:1002611	2	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110612_EXQ1_TaGe_SA_BC5_2.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110612_EXQ1_TaGe_SA_BC5_2.raw	cell
Sample 3	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	ERPR	run 14	NT=SILAC;AC=MS:1002611	3	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110612_EXQ1_TaGe_SA_BC5_3.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110612_EXQ1_TaGe_SA_BC5_3.raw	cell
Sample 3	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	ERPR	run 15	NT=SILAC;AC=MS:1002611	4	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110612_EXQ1_TaGe_SA_BC5_4.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110612_EXQ1_TaGe_SA_BC5_4.raw	cell
Sample 3	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	ERPR	run 16	NT=SILAC;AC=MS:1002611	5	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110612_EXQ1_TaGe_SA_BC5_5.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110612_EXQ1_TaGe_SA_BC5_5.raw	cell
Sample 3	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	ERPR	run 17	NT=SILAC;AC=MS:1002611	6	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110612_EXQ1_TaGe_SA_BC5_6.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110612_EXQ1_TaGe_SA_BC5_6.raw	cell
Sample 4	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	Her2	run 18	NT=SILAC;AC=MS:1002611	1	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110612_EXQ1_TaGe_SA_BC6_1.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110612_EXQ1_TaGe_SA_BC6_1.raw	cell
Sample 4	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	Her2	run 19	NT=SILAC;AC=MS:1002611	2	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110612_EXQ1_TaGe_SA_BC6_2.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110612_EXQ1_TaGe_SA_BC6_2.raw	cell
Sample 4	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	Her2	run 20	NT=SILAC;AC=MS:1002611	3	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110612_EXQ1_TaGe_SA_BC6_3.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110612_EXQ1_TaGe_SA_BC6_3.raw	cell
Sample 4	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	Her2	run 21	NT=SILAC;AC=MS:1002611	4	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110612_EXQ1_TaGe_SA_BC6_4.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110612_EXQ1_TaGe_SA_BC6_4.raw	cell
Sample 4	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	Her2	run 22	NT=SILAC;AC=MS:1002611	5	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110612_EXQ1_TaGe_SA_BC6_5.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110612_EXQ1_TaGe_SA_BC6_5.raw	cell
Sample 4	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	Her2	run 23	NT=SILAC;AC=MS:1002611	6	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110612_EXQ1_TaGe_SA_BC6_6.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110612_EXQ1_TaGe_SA_BC6_6.raw	cell
Sample 5	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	Her2	run 24	NT=SILAC;AC=MS:1002611	1	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110612_EXQ1_TaGe_SA_BC7_1.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110612_EXQ1_TaGe_SA_BC7_1.raw	cell
Sample 5	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	Her2	run 25	NT=SILAC;AC=MS:1002611	2	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110612_EXQ1_TaGe_SA_BC7_2.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110612_EXQ1_TaGe_SA_BC7_2.raw	cell
Sample 5	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	Her2	run 26	NT=SILAC;AC=MS:1002611	3	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110612_EXQ1_TaGe_SA_BC7_3.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110612_EXQ1_TaGe_SA_BC7_3.raw	cell
Sample 5	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	Her2	run 27	NT=SILAC;AC=MS:1002611	4	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110612_EXQ1_TaGe_SA_BC7_4.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110612_EXQ1_TaGe_SA_BC7_4.raw	cell
Sample 5	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	Her2	run 28	NT=SILAC;AC=MS:1002611	5	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110612_EXQ1_TaGe_SA_BC7_5.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110612_EXQ1_TaGe_SA_BC7_5.raw	cell
Sample 5	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	Her2	run 29	NT=SILAC;AC=MS:1002611	6	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110612_EXQ1_TaGe_SA_BC7_6.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110612_EXQ1_TaGe_SA_BC7_6.raw	cell
Sample 30	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	Her2	run 30	NT=SILAC;AC=MS:1002611	2	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110612_Q2_TaGe_SA_BC13_2.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110612_Q2_TaGe_SA_BC13_2.raw	cell
Sample 6	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	ERPR	run 31	NT=SILAC;AC=MS:1002611	1	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110612_Q2_TaGe_SA_BC1_1.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110612_Q2_TaGe_SA_BC1_1.raw	cell
Sample 6	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	ERPR	run 32	NT=SILAC;AC=MS:1002611	2	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110612_Q2_TaGe_SA_BC1_2.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110612_Q2_TaGe_SA_BC1_2.raw	cell
Sample 6	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	ERPR	run 33	NT=SILAC;AC=MS:1002611	3	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110612_Q2_TaGe_SA_BC1_3.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110612_Q2_TaGe_SA_BC1_3.raw	cell
Sample 6	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	ERPR	run 34	NT=SILAC;AC=MS:1002611	5	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110612_Q2_TaGe_SA_BC1_5.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110612_Q2_TaGe_SA_BC1_5.raw	cell
Sample 6	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	ERPR	run 35	NT=SILAC;AC=MS:1002611	6	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110612_Q2_TaGe_SA_BC1_6.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110612_Q2_TaGe_SA_BC1_6.raw	cell
Sample 7	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	ERPR	run 36	NT=SILAC;AC=MS:1002611	1	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110612_Q2_TaGe_SA_BC3_1.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110612_Q2_TaGe_SA_BC3_1.raw	cell
Sample 7	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	ERPR	run 37	NT=SILAC;AC=MS:1002611	2	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110612_Q2_TaGe_SA_BC3_2.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110612_Q2_TaGe_SA_BC3_2.raw	cell
Sample 7	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	ERPR	run 38	NT=SILAC;AC=MS:1002611	3	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110612_Q2_TaGe_SA_BC3_3.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110612_Q2_TaGe_SA_BC3_3.raw	cell
Sample 7	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	ERPR	run 39	NT=SILAC;AC=MS:1002611	4	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110612_Q2_TaGe_SA_BC3_4.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110612_Q2_TaGe_SA_BC3_4.raw	cell
Sample 7	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	ERPR	run 40	NT=SILAC;AC=MS:1002611	5	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110612_Q2_TaGe_SA_BC3_5.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110612_Q2_TaGe_SA_BC3_5.raw	cell
Sample 7	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	ERPR	run 41	NT=SILAC;AC=MS:1002611	6	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110612_Q2_TaGe_SA_BC3_6.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110612_Q2_TaGe_SA_BC3_6.raw	cell
Sample 8	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	ERPR	run 42	NT=SILAC;AC=MS:1002611	1	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110612_Q2_TaGe_SA_BC4_1.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110612_Q2_TaGe_SA_BC4_1.raw	cell
Sample 8	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	ERPR	run 43	NT=SILAC;AC=MS:1002611	2	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110612_Q2_TaGe_SA_BC4_2.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110612_Q2_TaGe_SA_BC4_2.raw	cell
Sample 8	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	ERPR	run 44	NT=SILAC;AC=MS:1002611	3	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110612_Q2_TaGe_SA_BC4_3.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110612_Q2_TaGe_SA_BC4_3.raw	cell
Sample 8	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	ERPR	run 45	NT=SILAC;AC=MS:1002611	4	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110612_Q2_TaGe_SA_BC4_4.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110612_Q2_TaGe_SA_BC4_4.raw	cell
Sample 8	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	ERPR	run 46	NT=SILAC;AC=MS:1002611	5	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110612_Q2_TaGe_SA_BC4_5.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110612_Q2_TaGe_SA_BC4_5.raw	cell
Sample 8	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	ERPR	run 47	NT=SILAC;AC=MS:1002611	6	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110612_Q2_TaGe_SA_BC4_6.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110612_Q2_TaGe_SA_BC4_6.raw	cell
Sample 9	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	Her2	run 48	NT=SILAC;AC=MS:1002611	1	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110616_EXQ1_TaGe_SA_BC10_1.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110616_EXQ1_TaGe_SA_BC10_1.raw	cell
Sample 9	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	Her2	run 49	NT=SILAC;AC=MS:1002611	2	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110616_EXQ1_TaGe_SA_BC10_2.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110616_EXQ1_TaGe_SA_BC10_2.raw	cell
Sample 9	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	Her2	run 50	NT=SILAC;AC=MS:1002611	3	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110616_EXQ1_TaGe_SA_BC10_3.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110616_EXQ1_TaGe_SA_BC10_3.raw	cell
Sample 9	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	Her2	run 51	NT=SILAC;AC=MS:1002611	4	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110616_EXQ1_TaGe_SA_BC10_4.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110616_EXQ1_TaGe_SA_BC10_4.raw	cell
Sample 9	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	Her2	run 52	NT=SILAC;AC=MS:1002611	5	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110616_EXQ1_TaGe_SA_BC10_5.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110616_EXQ1_TaGe_SA_BC10_5.raw	cell
Sample 9	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	Her2	run 53	NT=SILAC;AC=MS:1002611	6	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110616_EXQ1_TaGe_SA_BC10_6.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110616_EXQ1_TaGe_SA_BC10_6.raw	cell
Sample 10	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	triple negative	run 54	NT=SILAC;AC=MS:1002611	1	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110616_EXQ1_TaGe_SA_BC12_1.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110616_EXQ1_TaGe_SA_BC12_1.raw	cell
Sample 10	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	triple negative	run 55	NT=SILAC;AC=MS:1002611	2	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110616_EXQ1_TaGe_SA_BC12_2.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110616_EXQ1_TaGe_SA_BC12_2.raw	cell
Sample 10	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	triple negative	run 56	NT=SILAC;AC=MS:1002611	3	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110616_EXQ1_TaGe_SA_BC12_3.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110616_EXQ1_TaGe_SA_BC12_3.raw	cell
Sample 10	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	triple negative	run 57	NT=SILAC;AC=MS:1002611	4	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110616_EXQ1_TaGe_SA_BC12_4.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110616_EXQ1_TaGe_SA_BC12_4.raw	cell
Sample 10	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	triple negative	run 58	NT=SILAC;AC=MS:1002611	5	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110616_EXQ1_TaGe_SA_BC12_5.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110616_EXQ1_TaGe_SA_BC12_5.raw	cell
Sample 10	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	triple negative	run 59	NT=SILAC;AC=MS:1002611	6	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110616_EXQ1_TaGe_SA_BC12_6.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110616_EXQ1_TaGe_SA_BC12_6.raw	cell
Sample 11	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	ERPR	run 60	NT=SILAC;AC=MS:1002611	1	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110616_EXQ1_TaGe_SA_BC17_1.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110616_EXQ1_TaGe_SA_BC17_1.raw	cell
Sample 11	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	ERPR	run 61	NT=SILAC;AC=MS:1002611	2	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110616_EXQ1_TaGe_SA_BC17_2.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110616_EXQ1_TaGe_SA_BC17_2.raw	cell
Sample 11	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	ERPR	run 62	NT=SILAC;AC=MS:1002611	3	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110616_EXQ1_TaGe_SA_BC17_3.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110616_EXQ1_TaGe_SA_BC17_3.raw	cell
Sample 11	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	ERPR	run 63	NT=SILAC;AC=MS:1002611	4	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110616_EXQ1_TaGe_SA_BC17_4.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110616_EXQ1_TaGe_SA_BC17_4.raw	cell
Sample 11	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	ERPR	run 64	NT=SILAC;AC=MS:1002611	5	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110616_EXQ1_TaGe_SA_BC17_5.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110616_EXQ1_TaGe_SA_BC17_5.raw	cell
Sample 11	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	ERPR	run 65	NT=SILAC;AC=MS:1002611	6	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110616_EXQ1_TaGe_SA_BC17_6.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110616_EXQ1_TaGe_SA_BC17_6.raw	cell
Sample 12	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	triple negative	run 66	NT=SILAC;AC=MS:1002611	1	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110616_EXQ1_TaGe_SA_BC18_1.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110616_EXQ1_TaGe_SA_BC18_1.raw	cell
Sample 12	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	triple negative	run 67	NT=SILAC;AC=MS:1002611	2	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110616_EXQ1_TaGe_SA_BC18_2.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110616_EXQ1_TaGe_SA_BC18_2.raw	cell
Sample 12	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	triple negative	run 68	NT=SILAC;AC=MS:1002611	3	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110616_EXQ1_TaGe_SA_BC18_3.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110616_EXQ1_TaGe_SA_BC18_3.raw	cell
Sample 12	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	triple negative	run 69	NT=SILAC;AC=MS:1002611	4	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110616_EXQ1_TaGe_SA_BC18_4.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110616_EXQ1_TaGe_SA_BC18_4.raw	cell
Sample 12	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	triple negative	run 70	NT=SILAC;AC=MS:1002611	5	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110616_EXQ1_TaGe_SA_BC18_5.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110616_EXQ1_TaGe_SA_BC18_5.raw	cell
Sample 12	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	triple negative	run 71	NT=SILAC;AC=MS:1002611	6	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110616_EXQ1_TaGe_SA_BC18_6.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110616_EXQ1_TaGe_SA_BC18_6.raw	cell
Sample 13	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	ERPR	run 72	NT=SILAC;AC=MS:1002611	1	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110616_EXQ1_TaGe_SA_BC19_1.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110616_EXQ1_TaGe_SA_BC19_1.raw	cell
Sample 13	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	ERPR	run 73	NT=SILAC;AC=MS:1002611	2	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110616_EXQ1_TaGe_SA_BC19_2.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110616_EXQ1_TaGe_SA_BC19_2.raw	cell
Sample 13	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	ERPR	run 74	NT=SILAC;AC=MS:1002611	3	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110616_EXQ1_TaGe_SA_BC19_3.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110616_EXQ1_TaGe_SA_BC19_3.raw	cell
Sample 13	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	ERPR	run 75	NT=SILAC;AC=MS:1002611	4	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110616_EXQ1_TaGe_SA_BC19_4.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110616_EXQ1_TaGe_SA_BC19_4.raw	cell
Sample 13	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	ERPR	run 76	NT=SILAC;AC=MS:1002611	5	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110616_EXQ1_TaGe_SA_BC19_5.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110616_EXQ1_TaGe_SA_BC19_5.raw	cell
Sample 13	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	ERPR	run 77	NT=SILAC;AC=MS:1002611	6	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110616_EXQ1_TaGe_SA_BC19_6.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110616_EXQ1_TaGe_SA_BC19_6.raw	cell
Sample 14	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	Her2	run 78	NT=SILAC;AC=MS:1002611	1	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110616_EXQ1_TaGe_SA_BC20_1.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110616_EXQ1_TaGe_SA_BC20_1.raw	cell
Sample 14	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	Her2	run 79	NT=SILAC;AC=MS:1002611	2	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110616_EXQ1_TaGe_SA_BC20_2.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110616_EXQ1_TaGe_SA_BC20_2.raw	cell
Sample 14	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	Her2	run 80	NT=SILAC;AC=MS:1002611	3	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110616_EXQ1_TaGe_SA_BC20_3.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110616_EXQ1_TaGe_SA_BC20_3.raw	cell
Sample 14	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	Her2	run 81	NT=SILAC;AC=MS:1002611	4	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110616_EXQ1_TaGe_SA_BC20_4.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110616_EXQ1_TaGe_SA_BC20_4.raw	cell
Sample 14	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	Her2	run 82	NT=SILAC;AC=MS:1002611	5	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110616_EXQ1_TaGe_SA_BC20_5.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110616_EXQ1_TaGe_SA_BC20_5.raw	cell
Sample 14	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	Her2	run 83	NT=SILAC;AC=MS:1002611	6	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110616_EXQ1_TaGe_SA_BC20_6_110624160855.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110616_EXQ1_TaGe_SA_BC20_6_110624160855.raw	cell
Sample 15	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	ERPR	run 84	NT=SILAC;AC=MS:1002611	1	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110616_EXQ1_TaGe_SA_BC25_1.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110616_EXQ1_TaGe_SA_BC25_1.raw	cell
Sample 15	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	ERPR	run 85	NT=SILAC;AC=MS:1002611	2	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110616_EXQ1_TaGe_SA_BC25_2.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110616_EXQ1_TaGe_SA_BC25_2.raw	cell
Sample 15	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	ERPR	run 86	NT=SILAC;AC=MS:1002611	3	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110616_EXQ1_TaGe_SA_BC25_3.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110616_EXQ1_TaGe_SA_BC25_3.raw	cell
Sample 15	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	ERPR	run 87	NT=SILAC;AC=MS:1002611	4	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110616_EXQ1_TaGe_SA_BC25_4.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110616_EXQ1_TaGe_SA_BC25_4.raw	cell
Sample 15	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	ERPR	run 88	NT=SILAC;AC=MS:1002611	5	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110616_EXQ1_TaGe_SA_BC25_5.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110616_EXQ1_TaGe_SA_BC25_5.raw	cell
Sample 15	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	ERPR	run 89	NT=SILAC;AC=MS:1002611	6	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110616_EXQ1_TaGe_SA_BC25_6.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110616_EXQ1_TaGe_SA_BC25_6.raw	cell
Sample 16	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	ERPR	run 90	NT=SILAC;AC=MS:1002611	1	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110616_EXQ1_TaGe_SA_BC26_1.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110616_EXQ1_TaGe_SA_BC26_1.raw	cell
Sample 16	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	ERPR	run 91	NT=SILAC;AC=MS:1002611	2	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110616_EXQ1_TaGe_SA_BC26_2.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110616_EXQ1_TaGe_SA_BC26_2.raw	cell
Sample 16	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	ERPR	run 92	NT=SILAC;AC=MS:1002611	3	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110616_EXQ1_TaGe_SA_BC26_3.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110616_EXQ1_TaGe_SA_BC26_3.raw	cell
Sample 16	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	ERPR	run 93	NT=SILAC;AC=MS:1002611	4	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110616_EXQ1_TaGe_SA_BC26_4.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110616_EXQ1_TaGe_SA_BC26_4.raw	cell
Sample 16	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	ERPR	run 94	NT=SILAC;AC=MS:1002611	5	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110616_EXQ1_TaGe_SA_BC26_5.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110616_EXQ1_TaGe_SA_BC26_5.raw	cell
Sample 16	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	ERPR	run 95	NT=SILAC;AC=MS:1002611	6	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110616_EXQ1_TaGe_SA_BC26_6.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110616_EXQ1_TaGe_SA_BC26_6.raw	cell
Sample 17	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	ERPR	run 96	NT=SILAC;AC=MS:1002611	1	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110616_EXQ1_TaGe_SA_BC27_1.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110616_EXQ1_TaGe_SA_BC27_1.raw	cell
Sample 17	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	ERPR	run 97	NT=SILAC;AC=MS:1002611	2	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110616_EXQ1_TaGe_SA_BC27_2.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110616_EXQ1_TaGe_SA_BC27_2.raw	cell
Sample 17	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	ERPR	run 98	NT=SILAC;AC=MS:1002611	3	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110616_EXQ1_TaGe_SA_BC27_3.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110616_EXQ1_TaGe_SA_BC27_3.raw	cell
Sample 17	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	ERPR	run 99	NT=SILAC;AC=MS:1002611	4	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110616_EXQ1_TaGe_SA_BC27_4.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110616_EXQ1_TaGe_SA_BC27_4.raw	cell
Sample 17	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	ERPR	run 100	NT=SILAC;AC=MS:1002611	5	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110616_EXQ1_TaGe_SA_BC27_5.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110616_EXQ1_TaGe_SA_BC27_5.raw	cell
Sample 17	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	ERPR	run 101	NT=SILAC;AC=MS:1002611	6	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110616_EXQ1_TaGe_SA_BC27_6.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110616_EXQ1_TaGe_SA_BC27_6.raw	cell
Sample 18	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	Her2	run 102	NT=SILAC;AC=MS:1002611	1	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110616_EXQ1_TaGe_SA_BC33_1.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110616_EXQ1_TaGe_SA_BC33_1.raw	cell
Sample 18	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	Her2	run 103	NT=SILAC;AC=MS:1002611	2	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110616_EXQ1_TaGe_SA_BC33_2.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110616_EXQ1_TaGe_SA_BC33_2.raw	cell
Sample 18	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	Her2	run 104	NT=SILAC;AC=MS:1002611	3	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110616_EXQ1_TaGe_SA_BC33_3.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110616_EXQ1_TaGe_SA_BC33_3.raw	cell
Sample 18	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	Her2	run 105	NT=SILAC;AC=MS:1002611	4	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110616_EXQ1_TaGe_SA_BC33_4.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110616_EXQ1_TaGe_SA_BC33_4.raw	cell
Sample 18	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	Her2	run 106	NT=SILAC;AC=MS:1002611	5	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110616_EXQ1_TaGe_SA_BC33_5.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110616_EXQ1_TaGe_SA_BC33_5.raw	cell
Sample 18	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	Her2	run 107	NT=SILAC;AC=MS:1002611	6	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110616_EXQ1_TaGe_SA_BC33_6.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110616_EXQ1_TaGe_SA_BC33_6.raw	cell
Sample 19	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	Her2	run 108	NT=SILAC;AC=MS:1002611	1	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110616_EXQ1_TaGe_SA_BC34_1.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110616_EXQ1_TaGe_SA_BC34_1.raw	cell
Sample 19	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	Her2	run 109	NT=SILAC;AC=MS:1002611	2	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110616_EXQ1_TaGe_SA_BC34_2.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110616_EXQ1_TaGe_SA_BC34_2.raw	cell
Sample 19	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	Her2	run 110	NT=SILAC;AC=MS:1002611	3	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110616_EXQ1_TaGe_SA_BC34_3.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110616_EXQ1_TaGe_SA_BC34_3.raw	cell
Sample 19	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	Her2	run 111	NT=SILAC;AC=MS:1002611	4	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110616_EXQ1_TaGe_SA_BC34_4.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110616_EXQ1_TaGe_SA_BC34_4.raw	cell
Sample 19	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	Her2	run 112	NT=SILAC;AC=MS:1002611	5	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110616_EXQ1_TaGe_SA_BC34_5.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110616_EXQ1_TaGe_SA_BC34_5.raw	cell
Sample 19	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	Her2	run 113	NT=SILAC;AC=MS:1002611	6	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110616_EXQ1_TaGe_SA_BC34_6.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110616_EXQ1_TaGe_SA_BC34_6.raw	cell
Sample 20	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	ERPR	run 114	NT=SILAC;AC=MS:1002611	1	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110616_EXQ1_TaGe_SA_BC36_1.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110616_EXQ1_TaGe_SA_BC36_1.raw	cell
Sample 20	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	ERPR	run 115	NT=SILAC;AC=MS:1002611	2	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110616_EXQ1_TaGe_SA_BC36_2.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110616_EXQ1_TaGe_SA_BC36_2.raw	cell
Sample 20	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	ERPR	run 116	NT=SILAC;AC=MS:1002611	3	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110616_EXQ1_TaGe_SA_BC36_3.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110616_EXQ1_TaGe_SA_BC36_3.raw	cell
Sample 20	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	ERPR	run 117	NT=SILAC;AC=MS:1002611	4	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110616_EXQ1_TaGe_SA_BC36_4.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110616_EXQ1_TaGe_SA_BC36_4.raw	cell
Sample 20	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	ERPR	run 118	NT=SILAC;AC=MS:1002611	5	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110616_EXQ1_TaGe_SA_BC36_5.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110616_EXQ1_TaGe_SA_BC36_5.raw	cell
Sample 20	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	ERPR	run 119	NT=SILAC;AC=MS:1002611	6	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110616_EXQ1_TaGe_SA_BC36_6.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110616_EXQ1_TaGe_SA_BC36_6.raw	cell
Sample 21	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	Her2	run 120	NT=SILAC;AC=MS:1002611	1	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110616_EXQ1_TaGe_SA_BC37A_1_110708022331.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110616_EXQ1_TaGe_SA_BC37A_1_110708022331.raw	cell
Sample 21	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	Her2	run 121	NT=SILAC;AC=MS:1002611	2	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110616_EXQ1_TaGe_SA_BC37A_2_110708062628.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110616_EXQ1_TaGe_SA_BC37A_2_110708062628.raw	cell
Sample 21	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	Her2	run 122	NT=SILAC;AC=MS:1002611	3	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110616_EXQ1_TaGe_SA_BC37A_3.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110616_EXQ1_TaGe_SA_BC37A_3.raw	cell
Sample 21	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	Her2	run 123	NT=SILAC;AC=MS:1002611	4	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110616_EXQ1_TaGe_SA_BC37A_4.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110616_EXQ1_TaGe_SA_BC37A_4.raw	cell
Sample 21	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	Her2	run 124	NT=SILAC;AC=MS:1002611	5	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110616_EXQ1_TaGe_SA_BC37A_5.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110616_EXQ1_TaGe_SA_BC37A_5.raw	cell
Sample 21	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	Her2	run 125	NT=SILAC;AC=MS:1002611	6	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110616_EXQ1_TaGe_SA_BC37A_6.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110616_EXQ1_TaGe_SA_BC37A_6.raw	cell
Sample 22	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	Her2	run 126	NT=SILAC;AC=MS:1002611	1	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110616_EXQ1_TaGe_SA_BC9_1.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110616_EXQ1_TaGe_SA_BC9_1.raw	cell
Sample 22	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	Her2	run 127	NT=SILAC;AC=MS:1002611	2	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110616_EXQ1_TaGe_SA_BC9_2.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110616_EXQ1_TaGe_SA_BC9_2.raw	cell
Sample 22	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	Her2	run 128	NT=SILAC;AC=MS:1002611	3	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110616_EXQ1_TaGe_SA_BC9_3.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110616_EXQ1_TaGe_SA_BC9_3.raw	cell
Sample 22	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	Her2	run 129	NT=SILAC;AC=MS:1002611	4	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110616_EXQ1_TaGe_SA_BC9_4.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110616_EXQ1_TaGe_SA_BC9_4.raw	cell
Sample 22	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	Her2	run 130	NT=SILAC;AC=MS:1002611	5	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110616_EXQ1_TaGe_SA_BC9_5.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110616_EXQ1_TaGe_SA_BC9_5.raw	cell
Sample 22	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	Her2	run 131	NT=SILAC;AC=MS:1002611	6	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110616_EXQ1_TaGe_SA_BC9_6.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110616_EXQ1_TaGe_SA_BC9_6.raw	cell
Sample 23	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	not available	run 132	NT=SILAC;AC=MS:1002611	1	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110616_EXQ1_TaGe_SA_SSM_1.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110616_EXQ1_TaGe_SA_SSM_1.raw	cell
Sample 23	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	not available	run 133	NT=SILAC;AC=MS:1002611	2	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110616_EXQ1_TaGe_SA_SSM_2.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110616_EXQ1_TaGe_SA_SSM_2.raw	cell
Sample 23	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	not available	run 134	NT=SILAC;AC=MS:1002611	3	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110616_EXQ1_TaGe_SA_SSM_3.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110616_EXQ1_TaGe_SA_SSM_3.raw	cell
Sample 23	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	not available	run 135	NT=SILAC;AC=MS:1002611	4	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110616_EXQ1_TaGe_SA_SSM_4.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110616_EXQ1_TaGe_SA_SSM_4.raw	cell
Sample 23	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	not available	run 136	NT=SILAC;AC=MS:1002611	5	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110616_EXQ1_TaGe_SA_SSM_5.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110616_EXQ1_TaGe_SA_SSM_5.raw	cell
Sample 23	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	not available	run 137	NT=SILAC;AC=MS:1002611	6	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110616_EXQ1_TaGe_SA_SSM_6.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110616_EXQ1_TaGe_SA_SSM_6.raw	cell
Sample 24	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	Her2	run 138	NT=SILAC;AC=MS:1002611	1	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110617_EXQ2_TaGe_SA_BC29_1.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110617_EXQ2_TaGe_SA_BC29_1.raw	cell
Sample 24	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	Her2	run 139	NT=SILAC;AC=MS:1002611	2	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110617_EXQ2_TaGe_SA_BC29_2.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110617_EXQ2_TaGe_SA_BC29_2.raw	cell
Sample 24	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	Her2	run 140	NT=SILAC;AC=MS:1002611	3	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110617_EXQ2_TaGe_SA_BC29_3.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110617_EXQ2_TaGe_SA_BC29_3.raw	cell
Sample 24	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	Her2	run 141	NT=SILAC;AC=MS:1002611	4	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110617_EXQ2_TaGe_SA_BC29_4.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110617_EXQ2_TaGe_SA_BC29_4.raw	cell
Sample 24	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	Her2	run 142	NT=SILAC;AC=MS:1002611	5	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110617_EXQ2_TaGe_SA_BC29_5.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110617_EXQ2_TaGe_SA_BC29_5.raw	cell
Sample 24	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	Her2	run 143	NT=SILAC;AC=MS:1002611	6	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110617_EXQ2_TaGe_SA_BC29_6.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110617_EXQ2_TaGe_SA_BC29_6.raw	cell
Sample 25	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	Her2	run 144	NT=SILAC;AC=MS:1002611	1	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110617_EXQ2_TaGe_SA_BC30B_1.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110617_EXQ2_TaGe_SA_BC30B_1.raw	cell
Sample 25	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	Her2	run 145	NT=SILAC;AC=MS:1002611	2	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110617_EXQ2_TaGe_SA_BC30B_2.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110617_EXQ2_TaGe_SA_BC30B_2.raw	cell
Sample 25	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	Her2	run 146	NT=SILAC;AC=MS:1002611	3	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110617_EXQ2_TaGe_SA_BC30B_3.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110617_EXQ2_TaGe_SA_BC30B_3.raw	cell
Sample 25	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	Her2	run 147	NT=SILAC;AC=MS:1002611	4	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110617_EXQ2_TaGe_SA_BC30B_4.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110617_EXQ2_TaGe_SA_BC30B_4.raw	cell
Sample 25	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	Her2	run 148	NT=SILAC;AC=MS:1002611	5	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110617_EXQ2_TaGe_SA_BC30B_5.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110617_EXQ2_TaGe_SA_BC30B_5.raw	cell
Sample 25	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	Her2	run 149	NT=SILAC;AC=MS:1002611	6	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110617_EXQ2_TaGe_SA_BC30B_6.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110617_EXQ2_TaGe_SA_BC30B_6.raw	cell
Sample 26	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	ERPR	run 150	NT=SILAC;AC=MS:1002611	1	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110624_EXQ1_TaGe_SA_BC21_1.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110624_EXQ1_TaGe_SA_BC21_1.raw	cell
Sample 26	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	ERPR	run 151	NT=SILAC;AC=MS:1002611	2	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110624_EXQ1_TaGe_SA_BC21_2.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110624_EXQ1_TaGe_SA_BC21_2.raw	cell
Sample 26	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	ERPR	run 152	NT=SILAC;AC=MS:1002611	3	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110624_EXQ1_TaGe_SA_BC21_3.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110624_EXQ1_TaGe_SA_BC21_3.raw	cell
Sample 26	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	ERPR	run 153	NT=SILAC;AC=MS:1002611	4	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110624_EXQ1_TaGe_SA_BC21_4.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110624_EXQ1_TaGe_SA_BC21_4.raw	cell
Sample 26	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	ERPR	run 154	NT=SILAC;AC=MS:1002611	5	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110624_EXQ1_TaGe_SA_BC21_5.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110624_EXQ1_TaGe_SA_BC21_5.raw	cell
Sample 26	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	ERPR	run 155	NT=SILAC;AC=MS:1002611	6	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110624_EXQ1_TaGe_SA_BC21_6.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110624_EXQ1_TaGe_SA_BC21_6.raw	cell
Sample 27	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	triple negative	run 156	NT=SILAC;AC=MS:1002611	1	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110624_EXQ1_TaGe_SA_BC22_1.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110624_EXQ1_TaGe_SA_BC22_1.raw	cell
Sample 27	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	triple negative	run 157	NT=SILAC;AC=MS:1002611	2	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110624_EXQ1_TaGe_SA_BC22_2.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110624_EXQ1_TaGe_SA_BC22_2.raw	cell
Sample 27	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	triple negative	run 158	NT=SILAC;AC=MS:1002611	3	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110624_EXQ1_TaGe_SA_BC22_3.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110624_EXQ1_TaGe_SA_BC22_3.raw	cell
Sample 27	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	triple negative	run 159	NT=SILAC;AC=MS:1002611	4	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110624_EXQ1_TaGe_SA_BC22_4.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110624_EXQ1_TaGe_SA_BC22_4.raw	cell
Sample 27	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	triple negative	run 160	NT=SILAC;AC=MS:1002611	5	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110624_EXQ1_TaGe_SA_BC22_5.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110624_EXQ1_TaGe_SA_BC22_5.raw	cell
Sample 27	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	triple negative	run 161	NT=SILAC;AC=MS:1002611	6	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110624_EXQ1_TaGe_SA_BC22_6.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110624_EXQ1_TaGe_SA_BC22_6.raw	cell
Sample 28	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	triple negative	run 162	NT=SILAC;AC=MS:1002611	1	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110701_EXQ2_TaGe_SA_BC45_1.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110701_EXQ2_TaGe_SA_BC45_1.raw	cell
Sample 28	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	triple negative	run 163	NT=SILAC;AC=MS:1002611	2	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110701_EXQ2_TaGe_SA_BC45_2.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110701_EXQ2_TaGe_SA_BC45_2.raw	cell
Sample 28	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	triple negative	run 164	NT=SILAC;AC=MS:1002611	3	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110701_EXQ2_TaGe_SA_BC45_3.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110701_EXQ2_TaGe_SA_BC45_3.raw	cell
Sample 28	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	triple negative	run 165	NT=SILAC;AC=MS:1002611	4	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110701_EXQ2_TaGe_SA_BC45_4.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110701_EXQ2_TaGe_SA_BC45_4.raw	cell
Sample 28	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	triple negative	run 166	NT=SILAC;AC=MS:1002611	5	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110701_EXQ2_TaGe_SA_BC45_5.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110701_EXQ2_TaGe_SA_BC45_5.raw	cell
Sample 28	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	triple negative	run 167	NT=SILAC;AC=MS:1002611	6	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110701_EXQ2_TaGe_SA_BC45_6.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110701_EXQ2_TaGe_SA_BC45_6.raw	cell
Sample 29	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	not available	run 168	NT=SILAC;AC=MS:1002611	1	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110701_EXQ2_TaGe_SA_SSM1.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110701_EXQ2_TaGe_SA_SSM1.raw	cell
Sample 29	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	not available	run 169	NT=SILAC;AC=MS:1002611	2	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110701_EXQ2_TaGe_SA_SSM2.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110701_EXQ2_TaGe_SA_SSM2.raw	cell
Sample 29	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	not available	run 170	NT=SILAC;AC=MS:1002611	3	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110701_EXQ2_TaGe_SA_SSM3.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110701_EXQ2_TaGe_SA_SSM3.raw	cell
Sample 29	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	not available	run 171	NT=SILAC;AC=MS:1002611	4	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110701_EXQ2_TaGe_SA_SSM4.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110701_EXQ2_TaGe_SA_SSM4.raw	cell
Sample 29	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	not available	run 172	NT=SILAC;AC=MS:1002611	5	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110701_EXQ2_TaGe_SA_SSM5.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110701_EXQ2_TaGe_SA_SSM5.raw	cell
Sample 29	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	not available	run 173	NT=SILAC;AC=MS:1002611	6	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110701_EXQ2_TaGe_SA_SSM6.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110701_EXQ2_TaGe_SA_SSM6.raw	cell
Sample 30	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	triple negative	run 174	NT=SILAC;AC=MS:1002611	1	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110707_EXQ1_TaGe_SA_BC38_1.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110707_EXQ1_TaGe_SA_BC38_1.raw	cell
Sample 30	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	triple negative	run 175	NT=SILAC;AC=MS:1002611	2	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110707_EXQ1_TaGe_SA_BC38_2.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110707_EXQ1_TaGe_SA_BC38_2.raw	cell
Sample 30	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	triple negative	run 176	NT=SILAC;AC=MS:1002611	3	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110707_EXQ1_TaGe_SA_BC38_3.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110707_EXQ1_TaGe_SA_BC38_3.raw	cell
Sample 30	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	triple negative	run 177	NT=SILAC;AC=MS:1002611	4	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110707_EXQ1_TaGe_SA_BC38_4.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110707_EXQ1_TaGe_SA_BC38_4.raw	cell
Sample 30	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	triple negative	run 178	NT=SILAC;AC=MS:1002611	5	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110707_EXQ1_TaGe_SA_BC38_5.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110707_EXQ1_TaGe_SA_BC38_5.raw	cell
Sample 30	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	triple negative	run 179	NT=SILAC;AC=MS:1002611	6	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110707_EXQ1_TaGe_SA_BC38_6.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110707_EXQ1_TaGe_SA_BC38_6.raw	cell
Sample 31	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	triple negative	run 180	NT=SILAC;AC=MS:1002611	1	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110707_EXQ1_TaGe_SA_BC40_1_110713202722.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110707_EXQ1_TaGe_SA_BC40_1_110713202722.raw	cell
Sample 31	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	triple negative	run 181	NT=SILAC;AC=MS:1002611	2	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110707_EXQ1_TaGe_SA_BC40_2_110714003635.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110707_EXQ1_TaGe_SA_BC40_2_110714003635.raw	cell
Sample 31	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	triple negative	run 182	NT=SILAC;AC=MS:1002611	3	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110707_EXQ1_TaGe_SA_BC40_3.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110707_EXQ1_TaGe_SA_BC40_3.raw	cell
Sample 31	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	triple negative	run 183	NT=SILAC;AC=MS:1002611	4	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110707_EXQ1_TaGe_SA_BC40_4.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110707_EXQ1_TaGe_SA_BC40_4.raw	cell
Sample 31	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	triple negative	run 184	NT=SILAC;AC=MS:1002611	5	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110707_EXQ1_TaGe_SA_BC40_5_110714180918.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110707_EXQ1_TaGe_SA_BC40_5_110714180918.raw	cell
Sample 31	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	triple negative	run 185	NT=SILAC;AC=MS:1002611	6	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110707_EXQ1_TaGe_SA_BC40_6.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110707_EXQ1_TaGe_SA_BC40_6.raw	cell
Sample 32	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	triple negative	run 186	NT=SILAC;AC=MS:1002611	1	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110707_EXQ1_TaGe_SA_BC41_1.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110707_EXQ1_TaGe_SA_BC41_1.raw	cell
Sample 32	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	triple negative	run 187	NT=SILAC;AC=MS:1002611	2	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110707_EXQ1_TaGe_SA_BC41_2.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110707_EXQ1_TaGe_SA_BC41_2.raw	cell
Sample 32	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	triple negative	run 188	NT=SILAC;AC=MS:1002611	3	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110707_EXQ1_TaGe_SA_BC41_3.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110707_EXQ1_TaGe_SA_BC41_3.raw	cell
Sample 32	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	triple negative	run 189	NT=SILAC;AC=MS:1002611	4	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110707_EXQ1_TaGe_SA_BC41_4.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110707_EXQ1_TaGe_SA_BC41_4.raw	cell
Sample 32	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	triple negative	run 190	NT=SILAC;AC=MS:1002611	5	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110707_EXQ1_TaGe_SA_BC41_5.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110707_EXQ1_TaGe_SA_BC41_5.raw	cell
Sample 32	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	triple negative	run 191	NT=SILAC;AC=MS:1002611	6	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110707_EXQ1_TaGe_SA_BC41_6.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110707_EXQ1_TaGe_SA_BC41_6.raw	cell
Sample 33	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	triple negative	run 192	NT=SILAC;AC=MS:1002611	1	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110707_EXQ1_TaGe_SA_BC42_1.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110707_EXQ1_TaGe_SA_BC42_1.raw	cell
Sample 33	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	triple negative	run 193	NT=SILAC;AC=MS:1002611	2	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110707_EXQ1_TaGe_SA_BC42_2.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110707_EXQ1_TaGe_SA_BC42_2.raw	cell
Sample 33	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	triple negative	run 194	NT=SILAC;AC=MS:1002611	4	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110707_EXQ1_TaGe_SA_BC42_4.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110707_EXQ1_TaGe_SA_BC42_4.raw	cell
Sample 33	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	triple negative	run 195	NT=SILAC;AC=MS:1002611	5	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110707_EXQ1_TaGe_SA_BC42_5.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110707_EXQ1_TaGe_SA_BC42_5.raw	cell
Sample 33	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	triple negative	run 196	NT=SILAC;AC=MS:1002611	6	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110707_EXQ1_TaGe_SA_BC42_6.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110707_EXQ1_TaGe_SA_BC42_6.raw	cell
Sample 34	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	Her2	run 197	NT=SILAC;AC=MS:1002611	1	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110707_EXQ2_TaGe_SA_BC31_1.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110707_EXQ2_TaGe_SA_BC31_1.raw	cell
Sample 34	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	Her2	run 198	NT=SILAC;AC=MS:1002611	2	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110707_EXQ2_TaGe_SA_BC31_2.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110707_EXQ2_TaGe_SA_BC31_2.raw	cell
Sample 34	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	Her2	run 199	NT=SILAC;AC=MS:1002611	3	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110707_EXQ2_TaGe_SA_BC31_3.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110707_EXQ2_TaGe_SA_BC31_3.raw	cell
Sample 34	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	Her2	run 200	NT=SILAC;AC=MS:1002611	4	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110707_EXQ2_TaGe_SA_BC31_4.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110707_EXQ2_TaGe_SA_BC31_4.raw	cell
Sample 34	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	Her2	run 201	NT=SILAC;AC=MS:1002611	5	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110707_EXQ2_TaGe_SA_BC31_5.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110707_EXQ2_TaGe_SA_BC31_5.raw	cell
Sample 34	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	Her2	run 202	NT=SILAC;AC=MS:1002611	6	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110707_EXQ2_TaGe_SA_BC31_6.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110707_EXQ2_TaGe_SA_BC31_6.raw	cell
Sample 35	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	triple negative	run 203	NT=SILAC;AC=MS:1002611	1	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110707_EXQ2_TaGe_SA_BC46_1.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110707_EXQ2_TaGe_SA_BC46_1.raw	cell
Sample 35	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	triple negative	run 204	NT=SILAC;AC=MS:1002611	2	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110707_EXQ2_TaGe_SA_BC46_2.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110707_EXQ2_TaGe_SA_BC46_2.raw	cell
Sample 35	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	triple negative	run 205	NT=SILAC;AC=MS:1002611	3	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110707_EXQ2_TaGe_SA_BC46_3.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110707_EXQ2_TaGe_SA_BC46_3.raw	cell
Sample 35	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	triple negative	run 206	NT=SILAC;AC=MS:1002611	4	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110707_EXQ2_TaGe_SA_BC46_4.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110707_EXQ2_TaGe_SA_BC46_4.raw	cell
Sample 35	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	triple negative	run 207	NT=SILAC;AC=MS:1002611	5	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110707_EXQ2_TaGe_SA_BC46_5.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110707_EXQ2_TaGe_SA_BC46_5.raw	cell
Sample 35	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	triple negative	run 208	NT=SILAC;AC=MS:1002611	6	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110707_EXQ2_TaGe_SA_BC46_6.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110707_EXQ2_TaGe_SA_BC46_6.raw	cell
Sample 36	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	Her2	run 209	NT=SILAC;AC=MS:1002611	1	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110711_EXQ2_TaGe_SA_BC13_1.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110711_EXQ2_TaGe_SA_BC13_1.raw	cell
Sample 36	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	Her2	run 210	NT=SILAC;AC=MS:1002611	3	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110711_EXQ2_TaGe_SA_BC13_3_110712091614.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110711_EXQ2_TaGe_SA_BC13_3_110712091614.raw	cell
Sample 36	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	Her2	run 211	NT=SILAC;AC=MS:1002611	4	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110711_EXQ2_TaGe_SA_BC13_4.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110711_EXQ2_TaGe_SA_BC13_4.raw	cell
Sample 36	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	Her2	run 212	NT=SILAC;AC=MS:1002611	5	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110711_EXQ2_TaGe_SA_BC13_5.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110711_EXQ2_TaGe_SA_BC13_5.raw	cell
Sample 36	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	Her2	run 213	NT=SILAC;AC=MS:1002611	6	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110711_EXQ2_TaGe_SA_BC13_6.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110711_EXQ2_TaGe_SA_BC13_6.raw	cell
Sample 37	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	ERPR	run 214	NT=SILAC;AC=MS:1002611	1	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110711_EXQ2_TaGe_SA_BC14_1.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110711_EXQ2_TaGe_SA_BC14_1.raw	cell
Sample 37	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	ERPR	run 215	NT=SILAC;AC=MS:1002611	2	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110711_EXQ2_TaGe_SA_BC14_2.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110711_EXQ2_TaGe_SA_BC14_2.raw	cell
Sample 37	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	ERPR	run 216	NT=SILAC;AC=MS:1002611	3	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110711_EXQ2_TaGe_SA_BC14_3.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110711_EXQ2_TaGe_SA_BC14_3.raw	cell
Sample 37	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	ERPR	run 217	NT=SILAC;AC=MS:1002611	4	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110711_EXQ2_TaGe_SA_BC14_4.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110711_EXQ2_TaGe_SA_BC14_4.raw	cell
Sample 37	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	ERPR	run 218	NT=SILAC;AC=MS:1002611	5	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110711_EXQ2_TaGe_SA_BC14_5.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110711_EXQ2_TaGe_SA_BC14_5.raw	cell
Sample 37	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	ERPR	run 219	NT=SILAC;AC=MS:1002611	6	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110711_EXQ2_TaGe_SA_BC14_6.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110711_EXQ2_TaGe_SA_BC14_6.raw	cell
Sample 38	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	triple negative	run 220	NT=SILAC;AC=MS:1002611	1	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110711_EXQ2_TaGe_SA_BC15_1.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110711_EXQ2_TaGe_SA_BC15_1.raw	cell
Sample 38	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	triple negative	run 221	NT=SILAC;AC=MS:1002611	2	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110711_EXQ2_TaGe_SA_BC15_2.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110711_EXQ2_TaGe_SA_BC15_2.raw	cell
Sample 38	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	triple negative	run 222	NT=SILAC;AC=MS:1002611	3	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110711_EXQ2_TaGe_SA_BC15_3.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110711_EXQ2_TaGe_SA_BC15_3.raw	cell
Sample 38	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	triple negative	run 223	NT=SILAC;AC=MS:1002611	4	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110711_EXQ2_TaGe_SA_BC15_4.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110711_EXQ2_TaGe_SA_BC15_4.raw	cell
Sample 38	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	triple negative	run 224	NT=SILAC;AC=MS:1002611	5	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110711_EXQ2_TaGe_SA_BC15_5.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110711_EXQ2_TaGe_SA_BC15_5.raw	cell
Sample 38	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	triple negative	run 225	NT=SILAC;AC=MS:1002611	6	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110711_EXQ2_TaGe_SA_BC15_6.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110711_EXQ2_TaGe_SA_BC15_6.raw	cell
Sample 39	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	ERPR	run 226	NT=SILAC;AC=MS:1002611	1	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110823_EXQ3_TaGe_SA_BC23_1.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110823_EXQ3_TaGe_SA_BC23_1.raw	cell
Sample 39	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	ERPR	run 227	NT=SILAC;AC=MS:1002611	2	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110823_EXQ3_TaGe_SA_BC23_2.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110823_EXQ3_TaGe_SA_BC23_2.raw	cell
Sample 39	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	ERPR	run 228	NT=SILAC;AC=MS:1002611	3	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110823_EXQ3_TaGe_SA_BC23_3.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110823_EXQ3_TaGe_SA_BC23_3.raw	cell
Sample 39	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	ERPR	run 229	NT=SILAC;AC=MS:1002611	4	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110823_EXQ3_TaGe_SA_BC23_4.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110823_EXQ3_TaGe_SA_BC23_4.raw	cell
Sample 39	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	ERPR	run 230	NT=SILAC;AC=MS:1002611	5	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110823_EXQ3_TaGe_SA_BC23_5.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110823_EXQ3_TaGe_SA_BC23_5.raw	cell
Sample 39	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	ERPR	run 231	NT=SILAC;AC=MS:1002611	6	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110823_EXQ3_TaGe_SA_BC23_6.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110823_EXQ3_TaGe_SA_BC23_6.raw	cell
Sample 40	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	ERPR	run 232	NT=SILAC;AC=MS:1002611	1	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110823_EXQ3_TaGe_SA_BC28_1.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110823_EXQ3_TaGe_SA_BC28_1.raw	cell
Sample 40	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	ERPR	run 233	NT=SILAC;AC=MS:1002611	2	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110823_EXQ3_TaGe_SA_BC28_2.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110823_EXQ3_TaGe_SA_BC28_2.raw	cell
Sample 40	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	ERPR	run 234	NT=SILAC;AC=MS:1002611	3	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110823_EXQ3_TaGe_SA_BC28_3.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110823_EXQ3_TaGe_SA_BC28_3.raw	cell
Sample 40	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	ERPR	run 235	NT=SILAC;AC=MS:1002611	4	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110823_EXQ3_TaGe_SA_BC28_4.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110823_EXQ3_TaGe_SA_BC28_4.raw	cell
Sample 40	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	ERPR	run 236	NT=SILAC;AC=MS:1002611	5	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110823_EXQ3_TaGe_SA_BC28_5.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110823_EXQ3_TaGe_SA_BC28_5.raw	cell
Sample 40	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	ERPR	run 237	NT=SILAC;AC=MS:1002611	6	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110823_EXQ3_TaGe_SA_BC28_6.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110823_EXQ3_TaGe_SA_BC28_6.raw	cell
Sample 41	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	Her2	run 238	NT=SILAC;AC=MS:1002611	1	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110823_EXQ3_TaGe_SA_BC30_1.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110823_EXQ3_TaGe_SA_BC30_1.raw	cell
Sample 41	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	Her2	run 239	NT=SILAC;AC=MS:1002611	2	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110823_EXQ3_TaGe_SA_BC30_2.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110823_EXQ3_TaGe_SA_BC30_2.raw	cell
Sample 41	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	Her2	run 240	NT=SILAC;AC=MS:1002611	3	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110823_EXQ3_TaGe_SA_BC30_3.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110823_EXQ3_TaGe_SA_BC30_3.raw	cell
Sample 41	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	Her2	run 241	NT=SILAC;AC=MS:1002611	4	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110823_EXQ3_TaGe_SA_BC30_4.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110823_EXQ3_TaGe_SA_BC30_4.raw	cell
Sample 41	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	Her2	run 242	NT=SILAC;AC=MS:1002611	5	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110823_EXQ3_TaGe_SA_BC30_5.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110823_EXQ3_TaGe_SA_BC30_5.raw	cell
Sample 41	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	Her2	run 243	NT=SILAC;AC=MS:1002611	6	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110823_EXQ3_TaGe_SA_BC30_6.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110823_EXQ3_TaGe_SA_BC30_6.raw	cell
Sample 42	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	triple negative	run 244	NT=SILAC;AC=MS:1002611	1	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110823_EXQ3_TaGe_SA_BC32_1.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110823_EXQ3_TaGe_SA_BC32_1.raw	cell
Sample 42	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	triple negative	run 245	NT=SILAC;AC=MS:1002611	2	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110823_EXQ3_TaGe_SA_BC32_2_110831085923.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110823_EXQ3_TaGe_SA_BC32_2_110831085923.raw	cell
Sample 42	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	triple negative	run 246	NT=SILAC;AC=MS:1002611	3	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110823_EXQ3_TaGe_SA_BC32_3.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110823_EXQ3_TaGe_SA_BC32_3.raw	cell
Sample 42	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	triple negative	run 247	NT=SILAC;AC=MS:1002611	4	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110823_EXQ3_TaGe_SA_BC32_4.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110823_EXQ3_TaGe_SA_BC32_4.raw	cell
Sample 42	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	triple negative	run 248	NT=SILAC;AC=MS:1002611	5	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110823_EXQ3_TaGe_SA_BC32_5.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110823_EXQ3_TaGe_SA_BC32_5.raw	cell
Sample 42	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	triple negative	run 249	NT=SILAC;AC=MS:1002611	6	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110823_EXQ3_TaGe_SA_BC32_6.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110823_EXQ3_TaGe_SA_BC32_6.raw	cell
Sample 44	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	Her2	run 250	NT=SILAC;AC=MS:1002611	1	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110823_EXQ3_TaGe_SA_BC43_1.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110823_EXQ3_TaGe_SA_BC43_1.raw	cell
Sample 43	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	Her2	run 251	NT=SILAC;AC=MS:1002611	1	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110823_EXQ3_TaGe_SA_BC8_1.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110823_EXQ3_TaGe_SA_BC8_1.raw	cell
Sample 43	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	Her2	run 252	NT=SILAC;AC=MS:1002611	2	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110823_EXQ3_TaGe_SA_BC8_2.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110823_EXQ3_TaGe_SA_BC8_2.raw	cell
Sample 43	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	Her2	run 253	NT=SILAC;AC=MS:1002611	3	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110823_EXQ3_TaGe_SA_BC8_3.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110823_EXQ3_TaGe_SA_BC8_3.raw	cell
Sample 43	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	Her2	run 254	NT=SILAC;AC=MS:1002611	4	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110823_EXQ3_TaGe_SA_BC8_4.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110823_EXQ3_TaGe_SA_BC8_4.raw	cell
Sample 43	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	Her2	run 255	NT=SILAC;AC=MS:1002611	5	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110823_EXQ3_TaGe_SA_BC8_5.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110823_EXQ3_TaGe_SA_BC8_5.raw	cell
Sample 43	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	Her2	run 256	NT=SILAC;AC=MS:1002611	6	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110823_EXQ3_TaGe_SA_BC8_6.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110823_EXQ3_TaGe_SA_BC8_6.raw	cell
Sample 44	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	Her2	run 257	NT=SILAC;AC=MS:1002611	2	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110901_EXQ3_TaGe_SA_BC43_2.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110901_EXQ3_TaGe_SA_BC43_2.raw	cell
Sample 44	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	Her2	run 258	NT=SILAC;AC=MS:1002611	3	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110901_EXQ3_TaGe_SA_BC43_3.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110901_EXQ3_TaGe_SA_BC43_3.raw	cell
Sample 44	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	Her2	run 259	NT=SILAC;AC=MS:1002611	4	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110901_EXQ3_TaGe_SA_BC43_4.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110901_EXQ3_TaGe_SA_BC43_4.raw	cell
Sample 44	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	Her2	run 260	NT=SILAC;AC=MS:1002611	5	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110901_EXQ3_TaGe_SA_BC43_5.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110901_EXQ3_TaGe_SA_BC43_5.raw	cell
Sample 44	Homo sapiens	breast cancer cell	not available	not available	not available	not available	not available	breast cancer	Her2	run 261	NT=SILAC;AC=MS:1002611	6	AC=MS:1000081;NT=quadrupole	NT=Q Exactive;AC=MS:1001911	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002619/20110901_EXQ3_TaGe_SA_BC43_6.raw	AC=MS:1000422;NT=HCD	NT=Trypsin;AC=MS:1001251	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	6 ppm	20 ppm	20110901_EXQ3_TaGe_SA_BC43_6.raw	cell
